Cytokines and psychopathology: lessons from interferon-alpha - PubMed
- ️Thu Jan 01 2004
Review
Cytokines and psychopathology: lessons from interferon-alpha
Lucile Capuron et al. Biol Psychiatry. 2004.
Abstract
Interferon-alpha is a potent inducer of the cytokine network and is notorious for causing behavioral alterations. Studies on interferon-alpha-treated patients reveal at least two distinct syndromes: 1) a mood/cognitive syndrome that appears late during interferon-alpha therapy is responsive to antidepressants and is associated with activation of neuroendocrine pathways and altered serotonin metabolism; and 2) a neurovegetative syndrome characterized by psychomotor slowing, and fatigue that appears early during interferon-alpha treatment is antidepressant nonresponsive and may be mediated by alterations in basal ganglia dopamine metabolism. Findings from interferon-alpha may provide important clues regarding the pathophysiology and treatment of cytokine-induced behavioral changes in medically ill patients, while also potentially modeling the development of neuropsychiatric symptoms in patients without medical disorders.
Similar articles
-
Capuron L, Dantzer R, Miller AH. Capuron L, et al. J Soc Biol. 2003;197(2):151-6. J Soc Biol. 2003. PMID: 12910630 Review. French.
-
Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
Licinio J, Kling MA, Hauser P. Licinio J, et al. Semin Oncol. 1998 Feb;25(1 Suppl 1):30-8. Semin Oncol. 1998. PMID: 9482538 Review.
-
Mood and cognitive side effects of interferon-alpha therapy.
Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Valentine AD, et al. Semin Oncol. 1998 Feb;25(1 Suppl 1):39-47. Semin Oncol. 1998. PMID: 9482539 Review.
-
[Neuropsychiatric symptoms related to interferon alpha].
Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Kiejna A. Małyszczak K, et al. Psychiatr Pol. 2006 Jul-Aug;40(4):787-97. Psychiatr Pol. 2006. PMID: 17068950 Review. Polish.
-
Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
Raison CL, Demetrashvili M, Capuron L, Miller AH. Raison CL, et al. CNS Drugs. 2005;19(2):105-23. doi: 10.2165/00023210-200519020-00002. CNS Drugs. 2005. PMID: 15697325 Free PMC article. Review.
Cited by
-
Cytokine variations and mood disorders: influence of social stressors and social support.
Audet MC, McQuaid RJ, Merali Z, Anisman H. Audet MC, et al. Front Neurosci. 2014 Dec 16;8:416. doi: 10.3389/fnins.2014.00416. eCollection 2014. Front Neurosci. 2014. PMID: 25565946 Free PMC article. Review.
-
Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC. Salazar A, et al. Horm Behav. 2012 Aug;62(3):202-9. doi: 10.1016/j.yhbeh.2012.03.010. Epub 2012 Mar 31. Horm Behav. 2012. PMID: 22504306 Free PMC article. Review.
-
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.
Felger JC, Treadway MT. Felger JC, et al. Neuropsychopharmacology. 2017 Jan;42(1):216-241. doi: 10.1038/npp.2016.143. Epub 2016 Aug 2. Neuropsychopharmacology. 2017. PMID: 27480574 Free PMC article. Review.
-
Associations between vitamin D levels and depressive symptoms in healthy young adult women.
Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF. Kerr DC, et al. Psychiatry Res. 2015 May 30;227(1):46-51. doi: 10.1016/j.psychres.2015.02.016. Epub 2015 Mar 5. Psychiatry Res. 2015. PMID: 25791903 Free PMC article.
-
Savitz J, Frank MB, Victor T, Bebak M, Marino JH, Bellgowan PS, McKinney BA, Bodurka J, Kent Teague T, Drevets WC. Savitz J, et al. Brain Behav Immun. 2013 Jul;31:161-71. doi: 10.1016/j.bbi.2012.10.007. Epub 2012 Oct 12. Brain Behav Immun. 2013. PMID: 23064081 Free PMC article.